72 related articles for article (PubMed ID: 38573331)
1. Comparing prospectively assigned trial and real-world lung cancer patients.
Walker B; Ray HE; Shao P; D'Ambrosio C; White C; Walker MS
J Comp Eff Res; 2024 May; ():e230176. PubMed ID: 38785683
[No Abstract] [Full Text] [Related]
2. Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer.
Struebing A; McKibbon C; Ruan H; Mackay E; Dennis N; Velummailum R; He P; Tanaka Y; Xiong Y; Springford A; Rosenlund M
J Comp Eff Res; 2024 May; 13(5):e230175. PubMed ID: 38573331
[No Abstract] [Full Text] [Related]
3. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
[TBL] [Abstract][Full Text] [Related]
4. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
5. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.
Yang ZY; Liu L; Mao C; Wu XY; Huang YF; Hu XF; Tang JL
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009948. PubMed ID: 25400254
[TBL] [Abstract][Full Text] [Related]
7. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Dwan K; Boland A; Bates V; Vecchio F; Dundar Y; Jain P; Green JA
Cochrane Database Syst Rev; 2016 May; (5):CD010383. PubMed ID: 27223332
[TBL] [Abstract][Full Text] [Related]
8. The real-world impact of National Institute for Health and Care Excellence's real-world evidence framework.
Duffield S; Jónsson P
J Comp Eff Res; 2023 Nov; 12(11):e230135. PubMed ID: 37855246
[No Abstract] [Full Text] [Related]
9. Single-arm trials supporting the approval of anticancer medicinal products in the European Union: contextualization of trial results and observed clinical benefit.
Mulder J; Teerenstra S; van Hennik PB; Pasmooij AMG; Stoyanova-Beninska V; Voest EE; de Boer A
ESMO Open; 2023 Apr; 8(2):101209. PubMed ID: 37054504
[TBL] [Abstract][Full Text] [Related]
10. Data Challenges for Externally Controlled Trials: Viewpoint.
Velummailum RR; McKibbon C; Brenner DR; Stringer EA; Ekstrom L; Dron L
J Med Internet Res; 2023 Apr; 25():e43484. PubMed ID: 37018021
[TBL] [Abstract][Full Text] [Related]
11. Emulating Randomized Controlled Trials with Hybrid Control Arms in Oncology: A Case Study.
Sengupta S; Ntambwe I; Tan K; Liang Q; Paulucci D; Castellanos E; Fiore J; Lane S; Micsinai Balan M; Viraswami-Apanna K; Sethuraman V; Samant M; Tiwari R
Clin Pharmacol Ther; 2023 Apr; 113(4):867-877. PubMed ID: 36606735
[TBL] [Abstract][Full Text] [Related]
12. Use of Single-Arm Trials for US Food and Drug Administration Drug Approval in Oncology, 2002-2021.
Agrawal S; Arora S; Amiri-Kordestani L; de Claro RA; Fashoyin-Aje L; Gormley N; Kim T; Lemery S; Mehta GU; Scott EC; Singh H; Tang S; Theoret MR; Pazdur R; Kluetz PG; Beaver JA
JAMA Oncol; 2023 Feb; 9(2):266-272. PubMed ID: 36580315
[TBL] [Abstract][Full Text] [Related]
13. Stan: A Probabilistic Programming Language.
Carpenter B; Gelman A; Hoffman MD; Lee D; Goodrich B; Betancourt M; Brubaker MA; Guo J; Li P; Riddell A
J Stat Softw; 2017; 76():. PubMed ID: 36568334
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
